Cite
MLA Citation
Christopher H. Goss et al.. “An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CFTM 1.” ERJ open research, vol. 6, no. 4, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100172001773.0x0000fc